XELJANZ
Drug timelines are a Plus or Pro feature.
81 regulatory and trial events tracked for XELJANZ, covering 2009-08-13 to 2026-08-19. Get the full timeline:
Most recent: EMA Authorised: Xeljanz (tofacitinib) — Pfizer Europe MA EEIG
81 regulatory and trial events tracked for XELJANZ, covering 2009-08-13 to 2026-08-19. Get the full timeline:
Most recent: EMA Authorised: Xeljanz (tofacitinib) — Pfizer Europe MA EEIG